QA: Carisma Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2021_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 62,867,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 123,000
3 remainder_Assets 369,000
4 LiabilitiesCurrent 18,049,000
5 LiabilitiesNoncurrent 1,618,000
6 remainder_Liabilities 112,383,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,920,148
9 ResearchAndDevelopmentExpense 29,536,084
10 remainder_Expenses 71,502,165
11 remainder_Revenues 7,665,275
12 remainder_NetIncome 393,539
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 122,823,000
1 Liabilities 132,050,000
2 Expenses 114,958,397
3 Revenues 7,665,275
4 StockholdersEquity -9,227,000
5 NetIncome -106,899,583
6 ComprehensiveNetIncome -106,899,583
7 BaseVar 188,945,106
8 EconomicCapitalRatiobeforeLimitedLiability -0.997
9 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time